CA2404971A1 - Nouvelles proteine kinases humaines et nouvelles enzymes de type proteine kinase - Google Patents
Nouvelles proteine kinases humaines et nouvelles enzymes de type proteine kinase Download PDFInfo
- Publication number
- CA2404971A1 CA2404971A1 CA002404971A CA2404971A CA2404971A1 CA 2404971 A1 CA2404971 A1 CA 2404971A1 CA 002404971 A CA002404971 A CA 002404971A CA 2404971 A CA2404971 A CA 2404971A CA 2404971 A1 CA2404971 A1 CA 2404971A1
- Authority
- CA
- Canada
- Prior art keywords
- kinase
- polypeptide
- seq
- protein
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Gynecology & Obstetrics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pregnancy & Childbirth (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
Abstract
L'invention porte sur des polypeptides kinases, des séquences nucléotidiques codant pour ces polypeptides kinases, et sur différents produits et procédés utiles pour le diagnostic et le traitement de différentes maladies et états liés aux kinases. En recourant à la bioinformatique, on a pu identifier des PTK et STK de mammifères et en prédire la structure protéique.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19595300P | 2000-04-10 | 2000-04-10 | |
US60/195,953 | 2000-04-10 | ||
US20101500P | 2000-05-01 | 2000-05-01 | |
US60/201,015 | 2000-05-01 | ||
US21380500P | 2000-06-22 | 2000-06-22 | |
US60/213,805 | 2000-06-22 | ||
PCT/US2001/011675 WO2001077338A2 (fr) | 2000-04-10 | 2001-04-10 | Nouvelles proteine kinases humaines et nouvelles enzymes de type proteine kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2404971A1 true CA2404971A1 (fr) | 2001-10-18 |
Family
ID=27393539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002404971A Abandoned CA2404971A1 (fr) | 2000-04-10 | 2001-04-10 | Nouvelles proteine kinases humaines et nouvelles enzymes de type proteine kinase |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1278859A2 (fr) |
JP (1) | JP2003530110A (fr) |
AU (1) | AU2001251510A1 (fr) |
CA (1) | CA2404971A1 (fr) |
HK (1) | HK1052726A1 (fr) |
WO (1) | WO2001077338A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030083284A1 (en) * | 2001-08-01 | 2003-05-01 | Isis Pharmaceuticals Inc. | Antisense modulation of p70 S6 kinase expression |
CA2441700A1 (fr) * | 2001-03-22 | 2002-10-03 | Genentech, Inc. | Polypeptides et acides nucleiques pour bolekine |
WO2003064639A1 (fr) * | 2002-02-01 | 2003-08-07 | Bayer Healthcare Ag | Régulation du domaine catalytique humain de la protéine mekk |
WO2004099408A1 (fr) * | 2003-05-09 | 2004-11-18 | Research Association For Biotechnology | Nouvelle proteine et adn la codant |
CA2544807A1 (fr) | 2003-11-04 | 2005-05-19 | Metabolex, Inc. | Compositions et procedes d'utilisation d'une kinase en relation avec la kinase de signalisation de l'apoptose (askrk) |
WO2005083067A1 (fr) * | 2004-02-26 | 2005-09-09 | Bayer Healthcare Ag | Nouvelle protéine kinase activée par les mitogènes, map3kx, et ses utilisations |
JPWO2006054770A1 (ja) * | 2004-11-22 | 2008-06-05 | 国立大学法人 東京大学 | 新規mapキナーゼキナーゼキナーゼ(mapkkk) |
CN113740539B (zh) * | 2021-08-11 | 2023-07-25 | 中元汇吉生物技术股份有限公司 | 一种测定特异性生长因子的试剂盒 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736381A (en) * | 1995-05-19 | 1998-04-07 | Davis; Roger J. | Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
GB9719920D0 (en) * | 1997-09-19 | 1997-11-19 | Zeneca Ltd | Human Ste20-Like Stress Activated Serine/Threonine Kinase |
US6312934B1 (en) * | 1998-03-16 | 2001-11-06 | National Jewish Center For Immunology And Respiratory Medicine | Human MEKK proteins, corresponding nucleic acid molecules, and uses therefor |
EP1379628A2 (fr) * | 2000-12-06 | 2004-01-14 | Incyte Genomics, Inc. | Sequences de kinase et phosphatase, et leur utilisation |
-
2001
- 2001-04-10 CA CA002404971A patent/CA2404971A1/fr not_active Abandoned
- 2001-04-10 JP JP2001575192A patent/JP2003530110A/ja not_active Withdrawn
- 2001-04-10 AU AU2001251510A patent/AU2001251510A1/en not_active Abandoned
- 2001-04-10 WO PCT/US2001/011675 patent/WO2001077338A2/fr not_active Application Discontinuation
- 2001-04-10 EP EP01924901A patent/EP1278859A2/fr not_active Withdrawn
-
2003
- 2003-07-11 HK HK03105040.6A patent/HK1052726A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2001251510A1 (en) | 2001-10-23 |
HK1052726A1 (zh) | 2003-09-26 |
JP2003530110A (ja) | 2003-10-14 |
WO2001077338A3 (fr) | 2002-08-29 |
EP1278859A2 (fr) | 2003-01-29 |
WO2001077338A2 (fr) | 2001-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060140954A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
WO2001038503A2 (fr) | Nouvelles proteines kinases humaines et enzymes analogues | |
US20050125852A1 (en) | Novel kinases | |
US20070202107A1 (en) | Novel kinases | |
US20050142625A1 (en) | Antibodies against PAK5 | |
EP1180151A2 (fr) | Proteines kinases | |
CA2398430A1 (fr) | Nouvelles proteines kinases humaines et enzymes semblables aux proteines kinases | |
CA2404971A1 (fr) | Nouvelles proteine kinases humaines et nouvelles enzymes de type proteine kinase | |
EP1088079A2 (fr) | Kinases en rapport avec nek et avec bub1 | |
US20060188974A1 (en) | Human protein kinases and protein kinase-like enzymes | |
US20030211989A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
US20040157306A1 (en) | Mammalian protein phosphatases | |
US20060216730A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
US20050054070A1 (en) | Mammalian protein phosphatases | |
US20060204994A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
US20020090703A1 (en) | Mammalian protein phosphatases | |
US20040009549A1 (en) | Method for detecting remote homologues and novel kinases identified with the method | |
WO2004069154A2 (fr) | Procede pour detecter des homologues eloignes et nouvelles kinases identifiees au moyen de ce procede | |
US20050084877A1 (en) | Mammalian protein phosphatases | |
EP1595946A2 (fr) | Protéines kinasese apparentées à la famille de STE20 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20070410 |